» Articles » PMID: 22460074

Contemporary Consensus Proposal on Criteria and Classification of Eosinophilic Disorders and Related Syndromes

Abstract

Eosinophilia is an important indicator of various neoplastic and nonneoplastic conditions. Depending on the underlying disease and mechanisms, eosinophil infiltration can lead to organ dysfunction, clinical symptoms, or both. During the past 2 decades, several different classifications of eosinophilic disorders and related syndromes have been proposed in various fields of medicine. Although criteria and definitions are, in part, overlapping, no global consensus has been presented to date. The Year 2011 Working Conference on Eosinophil Disorders and Syndromes was organized to update and refine the criteria and definitions for eosinophilic disorders and to merge prior classifications in a contemporary multidisciplinary schema. A panel of experts from the fields of immunology, allergy, hematology, and pathology contributed to this project. The expert group agreed on unifying terminologies and criteria and a classification that delineates various forms of hypereosinophilia, including primary and secondary variants based on specific hematologic and immunologic conditions, and various forms of the hypereosinophilic syndrome. For patients in whom no underlying disease or hypereosinophilic syndrome is found, the term hypereosinophilia of undetermined significance is introduced. The proposed novel criteria, definitions, and terminologies should assist in daily practice, as well as in the preparation and conduct of clinical trials.

Citing Articles

Hypereosinophilic Syndrome in a Patient With Complex Pulmonary Hypertension and Sjogren's Syndrome: A Case Report.

Wang D, Singh H, Miller A, VonTungeln C, Banker L Cureus. 2025; 17(2):e78486.

PMID: 40051923 PMC: 11884384. DOI: 10.7759/cureus.78486.


More Than Just Stool: Hypereosinophilic Syndrome Presenting as Persistent Diarrhea in a Patient With Ulcerative Colitis.

Gruber S, Gallagher M, Malik M, Hall M J Brown Hosp Med. 2025; 3(4):9-12.

PMID: 40026549 PMC: 11864473. DOI: 10.56305/001c.122954.


Idiopathic Hypereosinophilic Syndrome With Cutaneous Manifestations: A Case Report.

Foreman N, Neves A, Rocha J, Dias M, Almeida J Cureus. 2025; 16(12):e76638.

PMID: 39881915 PMC: 11779529. DOI: 10.7759/cureus.76638.


The Cleveland Clinic experience of eosinophilic myocarditis in the setting of hypereosinophilic syndrome: demographics, cardiac imaging, and outcomes.

Reeder M, Okushi Y, Lo Presti Vega S, Prasad R, Grimm R, Griffin B Cardiovasc Diagn Ther. 2025; 14(6):1122-1133.

PMID: 39790190 PMC: 11707478. DOI: 10.21037/cdt-24-347.


Idiopathic eosinophilia complicated with cryptococcal meningitis: a case report.

Liu Z, Lou Y, Ji Y, Zhao C, Li L J Int Med Res. 2024; 52(12):3000605241305437.

PMID: 39703993 PMC: 11662334. DOI: 10.1177/03000605241305437.


References
1.
Tefferi A, Vardiman J . Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia. 2007; 22(1):14-22. DOI: 10.1038/sj.leu.2404955. View

2.
Metzgeroth G, Walz C, Score J, Siebert R, Schnittger S, Haferlach C . Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphoma. Leukemia. 2007; 21(6):1183-8. DOI: 10.1038/sj.leu.2404662. View

3.
Tefferi A, Skoda R, Vardiman J . Myeloproliferative neoplasms: contemporary diagnosis using histology and genetics. Nat Rev Clin Oncol. 2009; 6(11):627-37. DOI: 10.1038/nrclinonc.2009.149. View

4.
Roufosse F, Cogan E, Goldman M . Lymphocytic variant hypereosinophilic syndromes. Immunol Allergy Clin North Am. 2007; 27(3):389-413. DOI: 10.1016/j.iac.2007.07.002. View

5.
Simon H, Rothenberg M, Bochner B, Weller P, Wardlaw A, Wechsler M . Refining the definition of hypereosinophilic syndrome. J Allergy Clin Immunol. 2010; 126(1):45-9. PMC: 3400024. DOI: 10.1016/j.jaci.2010.03.042. View